Little Zosano takes another beating as the FDA slaps down their application for a migraine patch
Zosano $ZSAN has officially come up short in its bid to develop a migraine patch.
The FDA rejected the company’s application to repurpose the triptan …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
